Abstract
The in vitro antibacterial and antifungal activities of six benzimidazole and benzoxazole derivatives were tested against standard strains and 59 clinical isolates. Of the six compounds, only compounds II and III (both benzoxazoles) were active, whereas the rest were devoid of any activity. Considerable growth inhibition of all of the standard strains, including fungi and gram-positive and gram-negative bacteria, resulted when they were treated with these compounds. Fifty-nine clinical isolates of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were tested for susceptibility to the two compounds. The most susceptible were the S. aureus isolates. The two compounds were of comparable activity against all of the isolates, with compound III showing a slightly higher activity than compound II. Their respective minimal inhibitory concentrations for 90% inhibition of S. aureus were 25 and 50 microgram/ml. The gram-negative bacteria were resistant to the two compounds and required minimal inhibitory concentrations of 200 microgram/ml for a similar degree of inhibition.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cavalleri B., Volpe G., Arioli V., Pizzocheri F., Diena A. Synthesis and biological activity of new 2-nitroimidazole derivatives. J Med Chem. 1978 Aug;21(8):781–784. doi: 10.1021/jm00206a012. [DOI] [PubMed] [Google Scholar]
- Cosar C., Crisan C., Horclois R., Jacob R. M., Robert J., Tchelitcheff S., Vaupré R. Nitro-imidazoles--Préparation et activité chimiothérapeutique. Arzneimittelforschung. 1966 Jan;16(1):23–29. [PubMed] [Google Scholar]
- Cuckler A. C., Mezey K. C. The therapeutic efficacy of thiabendazole for helminthic infections in man; a literature review. Arzneimittelforschung. 1966 Mar;16(3):411–428. [PubMed] [Google Scholar]
- HOLLINSHEAD A. C., SMITH P. K. Effects of certain purines and related compounds on virus propagation. J Pharmacol Exp Ther. 1958 May;123(1):54–62. [PubMed] [Google Scholar]
- Maxwell W. A., Brody G. Antifungal activity of selected benzimidazole compounds. Appl Microbiol. 1971 May;21(5):944–945. doi: 10.1128/am.21.5.944-945.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NAKAMURA S. Structure of Azomycin, a new antibiotic. Pharm Bull. 1955 Oct;3(5):379–383. doi: 10.1248/cpb1953.3.379. [DOI] [PubMed] [Google Scholar]
- O'Sullivan D. G., Wallis A. K. Antiviral benzimidazoles. Direct 1-substitution of 2-(- -hydroxybenzyl)benzimidazole and related compounds. J Med Chem. 1972 Jan;15(1):103–104. doi: 10.1021/jm00271a032. [DOI] [PubMed] [Google Scholar]
- Walker K. A., Braemer A. C., Hitt S., Jones R. E., Matthews T. R. 1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl]-1H-imidazole nitrate, a new potent antifungal agent. J Med Chem. 1978 Aug;21(8):840–843. doi: 10.1021/jm00206a028. [DOI] [PubMed] [Google Scholar]